drugset / Trial / NCT06591338

Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

NCT06591338

Phase 3 Recruiting 900 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2024-09-01
Primary completion
2025-09-15
Completion
2025-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Comparator Ticagrelor Small molecule 90 mg
Comparator Aspirin Small molecule 75 mg Oral

Indications